BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6596298)

  • 1. The role of immunomodulators in the production of lipid mediators by macrophages (M phi).
    Roubin R; Drapier JC; Petit JF; Benveniste J
    Int J Tissue React; 1984; 6(5):373-8. PubMed ID: 6596298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity.
    Roubin R; Dulioust A; Haye-Legrand I; Ninio E; Benveniste J
    J Immunol; 1986 Mar; 136(5):1796-802. PubMed ID: 3950403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of platelet-activating factor (PAF-acether) and leukotrienes C and D from inflammatory macrophages.
    Roubin R; Mencia-Huerta JM; Benveniste J
    Eur J Immunol; 1982 Feb; 12(2):141-6. PubMed ID: 6122581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants.
    Drapier JC; Roubin R; Petit JF; Benveniste J
    Biochim Biophys Acta; 1983 Mar; 751(1):90-8. PubMed ID: 6131693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
    Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
    J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.
    Dulioust A; Vivier E; Meslier N; Roubin R; Haye-Legrand I; Benveniste J
    Biochem J; 1989 Oct; 263(1):165-71. PubMed ID: 2513801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the oxidative burst of macrophages by lipid mediators.
    Parnham MJ; Winkelman J; Hartung HP; Hadding U
    Agents Actions Suppl; 1984; 14():215-26. PubMed ID: 6433680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of prostaglandins, leukotrienes and paf-acether by macrophages.
    Roubin R; Benveniste J
    Comp Immunol Microbiol Infect Dis; 1985; 8(2):109-18. PubMed ID: 3910339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of paf-acether by E. coli K12].
    Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
    C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism.
    Boraschi D; Censini S; Bartalini M; Scapigliati G; Barbarulli G; Vicenzi E; Donati MB; Tagliabue A
    J Immunol; 1984 Apr; 132(4):1987-92. PubMed ID: 6321595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
    J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages.
    Bachelet M; Adolfs MJ; Masliah J; Bereziat G; Vargaftig BB; Bonta IL
    Eur J Pharmacol; 1988 Apr; 149(1-2):73-8. PubMed ID: 2840303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosanoid production by peritoneal and splenic macrophages in mice depleted of bone marrow by 89Sr.
    Shibata Y; Bautista AP; Pennington SN; Humes JL; Volkman A
    Am J Pathol; 1987 Apr; 127(1):75-82. PubMed ID: 3031987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis-stimulated macrophages. Production of prostaglandins and SRS-A, and prostaglandin effects on macrophage activation.
    Baggiolini M; Schnyder J; Dewald B; Bretz U; Payne TG
    Immunobiology; 1982 Apr; 161(3-4):369-75. PubMed ID: 6807833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
    Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
    Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferons inhibit LTC4 production in murine macrophages.
    Boraschi D; Censini S; Bartalini M; Ghiara P; Di Simplicio P; Tagliabue A
    J Immunol; 1987 Jun; 138(12):4341-6. PubMed ID: 2438341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced release of hydrogen peroxide and metabolites of arachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters.
    Lewis JG; Adams DO
    Cancer Res; 1986 Nov; 46(11):5696-700. PubMed ID: 3019532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1.
    Shikano M; Masuzawa Y; Yazawa K
    J Immunol; 1993 Apr; 150(8 Pt 1):3525-33. PubMed ID: 8468486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons.
    Boraschi D; Censini S; Bartalini M; Tagliabue A
    J Immunol; 1985 Jul; 135(1):502-5. PubMed ID: 3923110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.